Literature DB >> 25395358

Evaluation of hypericin: effect of aggregation on targeting biodistribution.

Xuejiao Liu1, Cuihua Jiang, Yue Li, Wei Liu, Nan Yao, Meng Gao, Yun Ji, Dejian Huang, Zhiqi Yin, Ziping Sun, Yicheng Ni, Jian Zhang.   

Abstract

Hypericin (Hy) has shown great promise as a necrosis-avid agent in cancer imaging and therapy. Given the highly hydrophobic and π-conjugated planarity characteristics, Hy tends to form aggregates. To investigate the effect of aggregation on targeting biodistribution, nonaggregated formulation (Non-Ag), aggregated formulation with overconcentrated Hy in dimethyl sulfoxide (Ag-DMSO) solution, and aggregated formulation in water solution (Ag-water) were selected by fluorescence measurement. They were labeled with ¹³¹I and evaluated for the necrosis affinity in rat model of reperfused hepatic infarction by gamma counting and autoradiography. The radioactivity ratio of necrotic liver/normal liver was 17.1, 7.9, and 6.4 for Non-Ag, Ag-DMSO, and Ag-water, respectively. The accumulation of two aggregated formulations (Ag-DMSO and Ag-water) in organs of mononuclear phagocyte system (MPS) was 2.62 ± 0.22 and 3.96 ± 0.30 %ID/g in the lung, and 1.44 ± 0.29 and 1.51 ± 0.23 %ID/g in the spleen, respectively. The biodistribution detected by autoradiography showed the same trend as by gamma counting. In conclusion, the Non-Ag showed better targeting biodistribution and less accumulation in MPS organs than aggregated formulations of Hy. The two aggregated formulations showed significantly lower and higher accumulation in targeting organ and MPS organs, respectively.
© 2014 Wiley Periodicals, Inc. and the American Pharmacists Association.

Entities:  

Keywords:  aggregation; autoradiography; distribution; drug effects; drug targeting; fluorescence spectroscopy; formulation; mononuclear phagocyte system; radiolabeling; reperfused hepatic infarction

Mesh:

Substances:

Year:  2014        PMID: 25395358     DOI: 10.1002/jps.24230

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  13 in total

1.  Evaluation of Necrosis Avidity and Potential for Rapid Imaging of Necrotic Myocardium of Radioiodinated Hypocrellins.

Authors:  Qiaomei Jin; Juanzhi Zhao; Meng Gao; Yuanbo Feng; Wei Liu; Zhiqi Yin; Tiannv Li; Shaoli Song; Yicheng Ni; Jian Zhang; Dejian Huang; Dongjian Zhang
Journal:  Mol Imaging Biol       Date:  2018-08       Impact factor: 3.488

2.  Effects of Glycosylation on Biodistribution and Imaging Quality of Necrotic Myocardium of Iodine-131-Labeled Sennidins.

Authors:  Ling Li; Dongjian Zhang; Shengwei Yang; Shaoli Song; Jindian Li; Qin Wang; Cong Wang; Yuanbo Feng; Yicheng Ni; Jian Zhang; Wei Liu; Zhiqi Yin
Journal:  Mol Imaging Biol       Date:  2016-12       Impact factor: 3.488

Review 3.  New photosensitizers for photodynamic therapy.

Authors:  Heidi Abrahamse; Michael R Hamblin
Journal:  Biochem J       Date:  2016-02-15       Impact factor: 3.857

4.  Mechanism-driven modeling of chemical hepatotoxicity using structural alerts and an in vitro screening assay.

Authors:  Xuelian Jia; Xia Wen; Daniel P Russo; Lauren M Aleksunes; Hao Zhu
Journal:  J Hazard Mater       Date:  2022-05-20       Impact factor: 14.224

Review 5.  The evolving roles of radiolabeled quinones as small molecular probes in necrotic imaging.

Authors:  Chang Su; Yan Xu
Journal:  Br J Radiol       Date:  2020-05-21       Impact factor: 3.039

6.  131I-Evans blue: evaluation of necrosis targeting property and preliminary assessment of the mechanism in animal models.

Authors:  Qiaomei Jin; Xin Shan; Qi Luo; Dongjian Zhang; Yuanyu Zhao; Nan Yao; Fei Peng; Dejian Huang; Zhiqi Yin; Wei Liu; Jian Zhang
Journal:  Acta Pharm Sin B       Date:  2017-09-19       Impact factor: 11.413

Review 7.  Avenues to molecular imaging of dying cells: Focus on cancer.

Authors:  Anna A Rybczynska; Hendrikus H Boersma; Steven de Jong; Jourik A Gietema; Walter Noordzij; Rudi A J O Dierckx; Philip H Elsinga; Aren van Waarde
Journal:  Med Res Rev       Date:  2018-03-12       Impact factor: 12.944

8.  Updated developments on molecular imaging and therapeutic strategies directed against necrosis.

Authors:  Dongjian Zhang; Meng Gao; Qiaomei Jin; Yicheng Ni; Jian Zhang
Journal:  Acta Pharm Sin B       Date:  2019-02-13       Impact factor: 11.413

9.  A Model In Vitro Study Using Hypericin: Tumor-Versus Necrosis-Targeting Property and Possible Mechanisms.

Authors:  Yue Li; Shuncong Wang; Yuanyu Zhao; Hexige Saiyin; Xiaoyan He; Juanzhi Zhao; Ling Li; Ali Talebi; Gang Huang; Yicheng Ni
Journal:  Biology (Basel)       Date:  2020-01-07

Review 10.  Enhancing Breast Cancer Treatment Using a Combination of Cannabidiol and Gold Nanoparticles for Photodynamic Therapy.

Authors:  Dimakatso R Mokoena; Blassan P George; Heidi Abrahamse
Journal:  Int J Mol Sci       Date:  2019-09-26       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.